Lottie file
Jonathan de Jonge
COO, ARTPred
COO, ARTPred
Medisch technologische innovaties
Jonathan Dennis de Jonge is co-founder and COO of ARTPred B.V., the Netherlands; a company in the field of reproduction which is known for its CE-certified personalized predictive test for IVF-outcome: ReceptIVFity.
Jonathan graduated from the University of Maastricht on Environmental Health Science, earned his PhD on immunomodulation, completed his education in Toxicology and Bio-business. He was schooled as a professional in licensing, negotiation, business model innovation and technology transfer.
Jonathan started as a scientist at Maastricht University and the National Institute for Public Health and the Environment a.o. in the field of immunotoxicology. He earned his track-record as Business Developer specializing in startups and serial entrepreneur in numerous successful biotechnology start-ups.
Jonathan is the author of books, peer reviewed articles, reports and awarded business plans and is inventor of two patent applications.
Jonathan graduated from the University of Maastricht on Environmental Health Science, earned his PhD on immunomodulation, completed his education in Toxicology and Bio-business. He was schooled as a professional in licensing, negotiation, business model innovation and technology transfer.
Jonathan started as a scientist at Maastricht University and the National Institute for Public Health and the Environment a.o. in the field of immunotoxicology. He earned his track-record as Business Developer specializing in startups and serial entrepreneur in numerous successful biotechnology start-ups.
Jonathan is the author of books, peer reviewed articles, reports and awarded business plans and is inventor of two patent applications.
